Abstract
Nearly 25 million people are alive today after being diagnosed with cancer during the last 5 years. Despite these encouraging statistics, there is a need to more fully understand the impact of lifestyle-modifiable factors, such as PA on cancer mortality. To date, no randomised controlled trials have investigated the effects of PA on cancer-specific mortality or all-cause mortality in cancer survivors. However, a number of prospective cohort studies have reported negative associations between PA and cancer mortality. The most compelling observational evidence of the survival benefits to be gained from a physically activity lifestyle has emanated from studies of post-diagnosis PA in breast and colorectal cancer survivors. These studies have shown clear inverse associations between post-diagnosis PA and survival, with the benefits being independent of age, gender, obesity and disease stage at diagnosis. Three of the four cohort studies of breast cancer survivors showed that women who are achieving the equivalent of 30 min of moderate intensity PA on five or more days of the week can halve their risk of mortality up to 8 years of follow-up. For colorectal cancer survivors, current evidence suggests that higher levels of PA are required to achieve similar benefits. Habitual exercise might also have a role to play in retarding PCa progression and in counteracting the increased risk of CV mortality in PCa patients. However, there is a need for further studies of other cancer populations and randomised controlled trials to provide more robust data on the frequency, intensity, duration and type of PA which confers the greatest survival benefits to patients recovering from different forms of cancer and associated treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108.
Coleman MP, Quaresma M, Berrino F, et al. (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9:730–756.
Jones LW, Demark-Wahnefried W. (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026.
Blair SN, Kohl HW, III, Paffenbarger RS, Jr., Clark DG, Cooper KH, Gibbons LW. (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395–2401.
Kampert JB, Blair SN, Barlow CE, Kohl HW, III. (1996) Physical activity, physical fitness, and all-cause and cancer mortality: a prospective study of men and women. Ann Epidemiol 6:452–457.
Evenson KR, Stevens J, Cai J, Thomas R, Thomas O. (2003) The effect of cardiorespiratory fitness and obesity on cancer mortality in women and men. Med Sci Sports Exerc 35:270–277.
Laukkanen JA, Lakka TA, Rauramaa R, et al. (2001) Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med 161:825–831.
Lee CD, Blair SN. (2002) Cardiorespiratory fitness and smoking-related and total cancer mortality in men. Med Sci Sports Exerc 34:735–739.
Sawada SS, Muto T, Tanaka H, et al. (2003) Cardiorespiratory fitness and cancer mortality in Japanese men: a prospective study. Med Sci Sports Exerc 35:1546–1550.
Peel JB, Sui X, Matthews CE, et al. (2009) Cardiorespiratory fitness and digestive cancer mortality: findings from the aerobics center longitudinal study. Cancer Epidemiol Biomarkers Prev 18:1111–1117.
Peel JB, Sui X, Adams SA, Hebert JR, Hardin JW, Blair SN. (2009) A prospective study of cardiorespiratory fitness and breast cancer mortality. Med Sci Sports Exerc 41:742–748.
Arraiz GA, Wigle DT, Mao Y. (1992) Risk assessment of physical activity and physical fitness in the Canada health survey mortality follow-up study. J Clin Epidemiol 45:419–428.
Haskell WL, Lee IM, Pate RR, et al. (2007) Physical activity and public health: updated recommendation for adults from the American college of sports medicine and the american heart association. Med Sci Sports Exerc 39:1423–1434.
Department of Health 2004 Chief Medical Officer’s Report. Evidence on the impact of physical activity and its relationship to health. 2004. London, HSMO.
Leitzmann MF, Park Y, Blair A, et al. (2007) Physical activity recommendations and decreased risk of mortality. Arch Intern Med 167:2453–2460.
Orsini N, Mantzoros CS, Wolk A. (2008) Association of physical activity with cancer incidence, mortality, and survival: a population-based study of men. Br J Cancer 98:1864–1869.
Inoue M, Iso H, Yamamoto S, et al. (2008) Daily total physical activity level and premature death in men and women: Results from a large-scale population-based cohort study in Japan (JPHC study). Ann Epidemiol 18:522–530.
Wannamethee G, Shaper AG, Macfarlane PW. (1993) Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases. Am J Epidemiol 137:735–748.
Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. (2005) The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) 29:894–902.
Katzmarzyk PT, Church TS, Craig CL, Bouchard C. (2009) Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 41:998–1005.
Rohan TE, Fu W, Hiller JE. (1995) Physical activity and survival from breast cancer. Eur J Cancer Prev 4:419–424.
Borugian MJ, Sheps SB, Kim-Sing C, et al. (2004) Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol Biomarkers Prev 13:1163–1172.
Enger SM, Bernstein L. (2004) Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 90:2138–2141.
Abrahamson PE, Gammon MD, Lund MJ, et al. (2006) Recreational physical activity and survival among young women with breast cancer. Cancer 107:1777–1785.
Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS. (2009) Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 124:1954–1962.
Pate RR, Pratt M, Blair SN, et al. (1995) Physical activity and public health. A recommendation from the centers for disease control and prevention and the American college of sports medicine. JAMA 273:402–407.
Haydon AM, Macinnis RJ, English DR, Giles GG. (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55:62–67.
Irwin ML, Crumley D, McTiernan A, et al. (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study. Cancer 97:1746–1757.
Courneya KS, Friedenreich CM. (1997) Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med 3:215–226.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486.
Irwin ML, McTiernan A, Bernstein L, et al. (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36:1484–1491.
Pierce JP, Stefanick ML, Flatt SW, et al. (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25:2345–2351.
Holick CN, Newcomb PA, Trentham-Dietz A, et al. (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379–386.
Irwin ML, Smith AW, McTiernan A, et al. (2008) Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 26:3958–3964.
Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24:3535–3541.
Meyerhardt JA, Giovannucci EL, Holmes MD, et al. (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527–3534.
Scardino PT, Weaver R, Hudson MA. (1992) Early detection of prostate cancer. Hum Pathol 23:211–222.
Giovannucci E, Leitzmann M, Spiegelman D, et al. (1998) A prospective study of physical activity and prostate cancer in male health professionals. Cancer Res 58:5117–5122.
Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC. (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165:1005–1010.
Patel AV, Rodriguez C, Jacobs EJ, Solomon L, Thun MJ, Calle EE. (2005) Recreational physical activity and risk of prostate cancer in a large cohort of US men. Cancer Epidemiol Biomarkers Prev 14:275–279.
Nilsen TI, Romundstad PR, Vatten LJ. (2006) Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer 119:2943–2947.
Crespo CJ, Garcia-Palmieri MR, Smit E, et al. (2008) Physical activity and prostate cancer mortality in Puerto Rican men. J Phys Act Health 5:918–929.
Moore SC, Peters TM, Ahn J, et al. (2008) Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 17:2458–2466.
Ornish D, Weidner G, Fair WR, et al. (2005) Intensive lifestyle changes May affect the progression of prostate cancer. J Urol 174:1065–1069.
Tayek JA, Heber D, Byerley LO, Steiner B, Rajfer J, Swerdloff RS. (1990) Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism 39:1314–1319.
Smith MR, Finkelstein JS, McGovern FJ, et al. (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87:599–603.
Braga-Basaria M, Dobs AS, Muller DC, et al. (2006) Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24:3979–3983.
Braga-Basaria M, Muller DC, Carducci MA, Dobs AS, Basaria S. (2006) Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. Int J Impot Res 18:494–498.
Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS. (2006) Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106:581–588.
Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS. (2007) Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 110:1493–1500.
Tsai HK, D’Amico AV, Sadetsky N, Chen MH, Carroll PR. (2007) Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 99:1516–1524.
Hamer M, Stamatakis E, Saxton JM. (2009) The impact of physical activity on all-cause mortality in men and women after a cancer diagnosis. Cancer Causes Control 20:225–231.
Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. (2005) Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 98:1534–1540.
Hutnick NA, Williams NI, Kraemer WJ, et al. (2005) Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exerc 37:1827–1835.
Meijer EP, Goris AH, van Dongen JL, Bast A, Westerterp KR. (2002) Exercise-induced oxidative stress in older adults as a function of habitual activity level. J Am Geriatr Soc 50:349–353.
Campbell KL, McTiernan A. (2007) Exercise and biomarkers for cancer prevention studies. J Nutr 137:161S–169S.
Leung PS, Aronson WJ, Ngo TH, Golding LA, Barnard RJ. (2004) Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. J Appl Physiol 96:450–454.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Saxton, J. (2010). Exercise and Cancer Mortality. In: Saxton, J., Daley, A. (eds) Exercise and Cancer Survivorship. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1173-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1173-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1172-8
Online ISBN: 978-1-4419-1173-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)